TY  - GEN
AU  - García-Pérez, Javier
AU  - Bermejo, Mercedes
AU  - Ramírez-García, Almudena
AU  - de la Torre-Tarazona, Humberto Erick
AU  - Cascajero Díaz, Almudena
AU  - Castillo de la Osa, María
AU  - Jiménez Santana, Paloma
AU  - Aparicio Gómez, Marta
AU  - Calonge, Esther
AU  - Sancho-López, Aránzazu
AU  - Payares-Herrera, Concepción
AU  - Layunta Acero, Rocio
AU  - Vicente-Izquierdo, Laura
AU  - Avendaño-Solá, Cristina
AU  - Alcamí, José
AU  - Perez-Olmeda, Mayte
AU  - Díez-Fuertes, Francisco
PY  - 2023
DO  - 10.1002/jmv.28679
UR  - http://hdl.handle.net/20.500.12105/16083
AB  - The humoral immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern elicited by vaccination was evaluated in COVID-19 recovered individuals (Rec) separated 1-3 months (Rec2m) or 4-12 months (Rec9m)...
LA  - eng
PB  - Wiley
KW  - Omicron
KW  - Hybrid immunity
KW  - mRNA-1273
KW  - Neutralizing antibodies
KW  - Timing of vaccination
KW  - COVID-19
KW  - Humans
KW  - 2019-nCoV Vaccine mRNA-1273
KW  - SARS-CoV-2
KW  - mRNA Vaccines
KW  - Biological Assay
KW  - Vaccination
KW  - Antibodies, Neutralizing
KW  - Antibodies, Viral
KW  - Spike Glycoprotein, Coronavirus
TI  - Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern
TY  - research article
ER  -